Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2025;15(2): 428-439. doi: 10.34172/apb.43809
PMID: 40922739        PMCID: PMC12413957

Original Article

Synergistic Enhancement of Osimertinib Efficacy in Non-small Cell Lung Cancer Cells Through Epigallocatechin-3-Gallate: Mechanistic Insights Into YAP/TEAD/CTGF Axis Inhibition

Ashwini Somayaji 1 * ORCID, Chakrakodi Shashidhara Shastry 2

Cited by CrossRef:

1- Zhang W, Zhang X, Chen K, Wang Y. The epidermal growth factor receptor regulates YAP signalling and promotes diabetic retinal fibrosis by modulating the degradation of SAV1. J Transl Med. 2025;23(1) [Crossref]